• Mutation; HGNC; HGNC:1833; CEBPA; Simple; p.Gln311Ter (c.931C>T); ClinVar=VCV000851673; Zygosity=Heterozygous (PubMed=29955132).
  
• Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Ala (c.35G>C); ClinVar=VCV000219097; Zygosity=Heterozygous (PubMed=7947263; PubMed=29955132).
  
• Mutation; HGNC; HGNC:11998; TP53; Simple; c.672+1G>A; ClinVar=VCV000216078; Zygosity=Homozygous; Note=Splice donor mutation (PubMed=29955132).
  

PubMed=7947263; DOI=10.1111/j.1365-2141.1994.tb04904.x
Tohyama K., Tsutani H., Ueda T., Nakamura T., Yoshida Y.
Establishment and characterization of a novel myeloid cell line from the bone marrow of a patient with the myelodysplastic syndrome.
Br. J. Haematol. 87:235-242(1994)

PubMed=8547120; DOI=10.1111/j.1365-2141.1995.tb05391.x
Tohyama K., Tohyama Y., Nakayama T., Ueda T., Nakamura T., Yoshida Y.
A novel factor-dependent human myelodysplastic cell line, MDS92, contains haemopoietic cells of several lineages.
Br. J. Haematol. 91:795-799(1995)

PubMed=9195772; DOI=10.1016/s0925-5710(96)00563-4
Tohyama K.
Human factor-dependent leukemia cell lines.
Int. J. Hematol. 65:309-317(1997)

PubMed=11108571; DOI=10.1080/13684730050515787
Nakamura S., Ohnishi K., Yoshida H., Shinjo K., Takeshita A., Tohyama K., Ohno R., Koide Y.
Retrovirus-mediated gene transfer of granulocyte colony-stimulating factor receptor (G-CSFR) cDNA into MDS cells and induction of their differentiation by G-CSF.
Cytokines Cell. Mol. Ther. 6:61-70(2000)

DOI=10.1016/B978-0-12-221970-2.50457-5
Drexler H.G.
The leukemia-lymphoma cell line factsbook.
(In book) ISBN 9780122219702; pp.1-733; Academic Press; London; United Kingdom (2001)

PubMed=19344951; DOI=10.1016/j.leukres.2009.03.005
Drexler H.G., Dirks W.G., MacLeod R.A.F.
Many are called MDS cell lines: one is chosen.
Leuk. Res. 33:1011-1016(2009)

PubMed=29955132; DOI=10.1038/s41375-018-0189-7
Kida J.-i., Tsujioka T., Suemori S.-i., Okamoto S., Sakakibara K., Takahata T., Yamauchi T., Kitanaka A., Tohyama Y., Tohyama K.
An MDS-derived cell line and a series of its sublines serve as an in vitro model for the leukemic evolution of MDS.
Leukemia 32:1846-1850(2018)